Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Experimental validation of a FLUKA Monte Carlo simulation for carbon-ion radiotherapy monitoring via secondary ion tracking

P. Ochoa-Parra, L. Schweins, N. Abbani, L. Ghesquière-Diérickx, T. Gehrke, J. Jakubek, L. Marek, C. Granja, F. Dinkel, G. Echner, M. Winter, A. Mairani, S. Harrabi, O. Jäkel, J. Debus, M. Martišíková, L. Kelleter

. 2024 ; 51 (12) : 9217-9229. [pub] 20240922

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, validační studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc25003256

Grantová podpora
426970603 Deutsche Forschungsgemeinschaft
Nationales Centrum für Tumorerkrankungen Heidelberg

BACKGROUND: In-vivo monitoring methods of carbon ion radiotherapy (CIRT) includes explorations of nuclear reaction products generated by carbon-ion beams interacting with patient tissues. Our research group focuses on in-vivo monitoring of CIRT using silicon pixel detectors. Currently, we are conducting a prospective clinical trial as part of the In-Vivo Monitoring project (InViMo) at the Heidelberg Ion Beam Therapy Center (HIT) in Germany. We are using an innovative, in-house developed, non-contact fragment tracking system with seven mini-trackers based on the Timepix3 technology developed at CERN. PURPOSE: This article focuses on the implementation of the mini-tracker in Monte Carlo (MC) based on FLUKA simulations to monitor secondary charged nuclear fragments in CIRT. The main objective is to systematically evaluate the simulation accuracy for the InViMo project. METHODS: The implementation involved integrating the mini-tracker geometry and the scoring mechanism into the FLUKA MC simulation, utilizing the finely tuned HIT beam line. The systematic investigation included varying mini-tracker angles (from 15∘$15^\circ$ to 45∘$45^\circ$ in 5∘$5^\circ$ steps) during the irradiation of a head-sized phantom with therapeutic carbon-ion pencil beams. To evaluate our implemented FLUKA framework, a comparison was made between the experimental data and data obtained from MC simulations. To ensure the fidelity of our comparison, experiments were performed at the HIT using the parameters and setup established in the simulations. RESULTS: Our research demonstrates high accuracy in reproducing characteristic behaviors and dependencies of the monitoring method in terms of fragment distributions in the mini-tracker, track angles, emission profiles, and fragment numbers. Discrepancies in the number of detected fragments between the experimental data and the data obtained from MC simulations are less than 4% for the angles of interest in the InViMo detection system. CONCLUSIONS: Our study confirms the potential of our simulation framework to investigate the performance of monitoring inter-fractional anatomical changes in patients undergoing CIRT using secondary nuclear charged fragments escaping from the irradiated patient.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25003256
003      
CZ-PrNML
005      
20250206104212.0
007      
ta
008      
250121s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/mp.17408 $2 doi
035    __
$a (PubMed)39306865
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Ochoa-Parra, Pamela $u Heidelberg Institute for Radiation Oncology HIRO, National Center for Radiation Research in Oncology NCRO, Heidelberg, Germany $u Department of Physics and Astronomy, Heidelberg University, Heidelberg, Germany $u Department of Medical Physics in Radiation Oncology, German Cancer Research Center DKFZ, Heidelberg, Germany $1 https://orcid.org/0009000273737524
245    10
$a Experimental validation of a FLUKA Monte Carlo simulation for carbon-ion radiotherapy monitoring via secondary ion tracking / $c P. Ochoa-Parra, L. Schweins, N. Abbani, L. Ghesquière-Diérickx, T. Gehrke, J. Jakubek, L. Marek, C. Granja, F. Dinkel, G. Echner, M. Winter, A. Mairani, S. Harrabi, O. Jäkel, J. Debus, M. Martišíková, L. Kelleter
520    9_
$a BACKGROUND: In-vivo monitoring methods of carbon ion radiotherapy (CIRT) includes explorations of nuclear reaction products generated by carbon-ion beams interacting with patient tissues. Our research group focuses on in-vivo monitoring of CIRT using silicon pixel detectors. Currently, we are conducting a prospective clinical trial as part of the In-Vivo Monitoring project (InViMo) at the Heidelberg Ion Beam Therapy Center (HIT) in Germany. We are using an innovative, in-house developed, non-contact fragment tracking system with seven mini-trackers based on the Timepix3 technology developed at CERN. PURPOSE: This article focuses on the implementation of the mini-tracker in Monte Carlo (MC) based on FLUKA simulations to monitor secondary charged nuclear fragments in CIRT. The main objective is to systematically evaluate the simulation accuracy for the InViMo project. METHODS: The implementation involved integrating the mini-tracker geometry and the scoring mechanism into the FLUKA MC simulation, utilizing the finely tuned HIT beam line. The systematic investigation included varying mini-tracker angles (from 15∘$15^\circ$ to 45∘$45^\circ$ in 5∘$5^\circ$ steps) during the irradiation of a head-sized phantom with therapeutic carbon-ion pencil beams. To evaluate our implemented FLUKA framework, a comparison was made between the experimental data and data obtained from MC simulations. To ensure the fidelity of our comparison, experiments were performed at the HIT using the parameters and setup established in the simulations. RESULTS: Our research demonstrates high accuracy in reproducing characteristic behaviors and dependencies of the monitoring method in terms of fragment distributions in the mini-tracker, track angles, emission profiles, and fragment numbers. Discrepancies in the number of detected fragments between the experimental data and the data obtained from MC simulations are less than 4% for the angles of interest in the InViMo detection system. CONCLUSIONS: Our study confirms the potential of our simulation framework to investigate the performance of monitoring inter-fractional anatomical changes in patients undergoing CIRT using secondary nuclear charged fragments escaping from the irradiated patient.
650    12
$a metoda Monte Carlo $7 D009010
650    12
$a radioterapie těžkými ionty $7 D063193
650    _2
$a fantomy radiodiagnostické $7 D019047
650    _2
$a lidé $7 D006801
655    _2
$a časopisecké články $7 D016428
655    _2
$a validační studie $7 D023361
700    1_
$a Schweins, Luisa $u Heidelberg Institute for Radiation Oncology HIRO, National Center for Radiation Research in Oncology NCRO, Heidelberg, Germany $u Department of Physics and Astronomy, Heidelberg University, Heidelberg, Germany $u Department of Medical Physics in Radiation Oncology, German Cancer Research Center DKFZ, Heidelberg, Germany
700    1_
$a Abbani, Nelly $u Heidelberg Institute for Radiation Oncology HIRO, National Center for Radiation Research in Oncology NCRO, Heidelberg, Germany $u Department of Medical Physics in Radiation Oncology, German Cancer Research Center DKFZ, Heidelberg, Germany $u Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
700    1_
$a Ghesquière-Diérickx, Laura $u Heidelberg Institute for Radiation Oncology HIRO, National Center for Radiation Research in Oncology NCRO, Heidelberg, Germany $u Department of Physics and Astronomy, Heidelberg University, Heidelberg, Germany $u Medical Faculty, Heidelberg University, Heidelberg, Germany
700    1_
$a Gehrke, Tim $u Heidelberg Institute for Radiation Oncology HIRO, National Center for Radiation Research in Oncology NCRO, Heidelberg, Germany $u Department of Medical Physics in Radiation Oncology, German Cancer Research Center DKFZ, Heidelberg, Germany $u National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and University Medical Center Heidelberg, Heidelberg, Germany
700    1_
$a Jakubek, Jan $u ADVACAM s.r.o., Prague, Czech Republic
700    1_
$a Marek, Lukas $u ADVACAM s.r.o., Prague, Czech Republic
700    1_
$a Granja, Carlos $u ADVACAM s.r.o., Prague, Czech Republic
700    1_
$a Dinkel, Fabian $u Heidelberg Institute for Radiation Oncology HIRO, National Center for Radiation Research in Oncology NCRO, Heidelberg, Germany $u Department of Medical Physics in Radiation Oncology, German Cancer Research Center DKFZ, Heidelberg, Germany
700    1_
$a Echner, Gernot $u Heidelberg Institute for Radiation Oncology HIRO, National Center for Radiation Research in Oncology NCRO, Heidelberg, Germany $u Department of Medical Physics in Radiation Oncology, German Cancer Research Center DKFZ, Heidelberg, Germany
700    1_
$a Winter, Marcus $u Heidelberg Ion Beam Therapy Center (HIT), Heidelberg, Germany
700    1_
$a Mairani, Andrea $u Heidelberg Ion Beam Therapy Center (HIT), Heidelberg, Germany
700    1_
$a Harrabi, Semi $u Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany
700    1_
$a Jäkel, Oliver $u Heidelberg Institute for Radiation Oncology HIRO, National Center for Radiation Research in Oncology NCRO, Heidelberg, Germany $u Department of Medical Physics in Radiation Oncology, German Cancer Research Center DKFZ, Heidelberg, Germany $u National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and University Medical Center Heidelberg, Heidelberg, Germany $u Heidelberg Ion Beam Therapy Center (HIT), Heidelberg, Germany
700    1_
$a Debus, Jürgen $u National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and University Medical Center Heidelberg, Heidelberg, Germany $u Heidelberg Ion Beam Therapy Center (HIT), Heidelberg, Germany $u Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany $u Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center DKFZ, Heidelberg, Germany
700    1_
$a Martišíková, Mária $u Heidelberg Institute for Radiation Oncology HIRO, National Center for Radiation Research in Oncology NCRO, Heidelberg, Germany $u Department of Medical Physics in Radiation Oncology, German Cancer Research Center DKFZ, Heidelberg, Germany $u National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and University Medical Center Heidelberg, Heidelberg, Germany
700    1_
$a Kelleter, Laurent $u Heidelberg Institute for Radiation Oncology HIRO, National Center for Radiation Research in Oncology NCRO, Heidelberg, Germany $u Department of Medical Physics in Radiation Oncology, German Cancer Research Center DKFZ, Heidelberg, Germany $u National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and University Medical Center Heidelberg, Heidelberg, Germany
773    0_
$w MED00003245 $t Medical physics $x 2473-4209 $g Roč. 51, č. 12 (2024), s. 9217-9229
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39306865 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206104208 $b ABA008
999    __
$a ok $b bmc $g 2263169 $s 1239263
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 51 $c 12 $d 9217-9229 $e 20240922 $i 2473-4209 $m Medical physics $n Med Phys $x MED00003245
GRA    __
$a 426970603 $p Deutsche Forschungsgemeinschaft
GRA    __
$p Nationales Centrum für Tumorerkrankungen Heidelberg
LZP    __
$a Pubmed-20250121

Najít záznam

Citační ukazatele

Možnosti archivace